Sex differences in biomarkers are further influenced by APOE-ε4 genotype, the most established genetic risk factor for AD: prior studies show that the association between APOE-ε4 and CSF tau levels are stronger in females relative to males24. This evidence concerns the gene APOE and Alzheimer disease.